ASSOCIATION OF –308TNF AND +252LTA SINGLE NUCLEOTIDE POLYMORPHISMS WITH HEMATOLOGICAL MALIGNANCIES IN CHILDREN FROM THE BASHKORTOSTAN REPUBLIC
Yakupova EV 1,* Krasavtceva TN2, Malyevsky OA2, Viktorova TV1
*Corresponding Author: Dr. Elvira V. Yakupova, Institute of Biochemistry and Genetics, Ufa Research Centre, Russian Academy of Science, Prospect Oktyabrya 69, Ufa 450054, Russia; Tel./Fax: +007-3472-356088; E-mail: ecolab_203@mail.ru
page: 9

REFERENCES

1. Cortes J, Kantarjian H. Acute lymphoblastic leuke­mia: a comprehensive review with emphasis on biology and therapy. Cancer 1995; 76(12): 2393-2417.

2. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFa-deficient mice: a critical requirement for TNFa in the formation of primary B cell follicles, follicular dendritic network and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996; 184(4): 1397-1411.

3. Salles G, Bienvenu J, Bastion Y, Barbier Y, Doche C, Warzocha K, Gutowski M, Rieux C, Coiffier B. Ele­vated circulating levels of TNFa and its p55 soluble re­ceptor are associated with an adverse prognosis in lym­phoma patients. Br J Hematol 1996; 93(2): 352-359.

4. Tracey K, Wei H, Manoque K, Fong Y, Hesse D, Nguyen H, Kuo G, Beutler B, Cotran R, Cerami A. Cach­ectin/tumor necrosis factor induses cachexia, anemia, and inflammation. J Exp Med 1988; 167(3): 1211-1227.

5. Warzocha K, Salles G, Bienvenu j, Bastion Y, Dumontet C, Renard N, Neidhard E, Coiffier B. The tu­mor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol 1997; 15(2):499-508.

6. Wilson A, de Vries N, Pociot F, di Giovine F, van der Putte L, Duff G. An allelic polymorphism within the human tumor necrosis factor a promoter region in strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177(2): 557-560.

7. Wilson A, Symons J, McDowell T, McDevitt H, Duff G. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94(7): 3195-3199.

8. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH. Polymor­phic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173(1): 209-219.

9. Mathew C. The isolation of high molecular weight eucariotic DNA. Meth Mol Biol 1984; 2: 31-34.

10. Stuber F, Udalova I, Book M, Drutskaya L, Kuprash D, Turetskaya R, Schade F, Nedospasov S. –308 Tumor necrosis factor (TNF) polymorphism is not associ­ated with survival in severe sepsis and is unrelated to lipo­polysaccharide inducibility of the human TNF promoter. J Inflamm 1995-96; 46(1): 42-50.

11. Day C, Grove J, Daly A, Stewart M, Avery P, Walker M. Tumor necrosis factor-a gene promoter poly­morphism and decreased insulin resistance. Diabetologia 1998; 41(4): 430-434.

12. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G. Genetic poly­morphisms in the tumor necrosis factor locus influence Non-Hodgkin’s lymphoma outcome. Blood 1998; 91(10): 3574-3581.

13. Roff D, Bentzen P. The statistical analysis of mitochondrial DNA: c2 and problem of small samples. Mol Biol Evol 1989; 6(5): 539-545.


14. Takashiba S, Shapira L, Amar S, Van Dyke T. Cloning and characterization of human TNFa promoter region. Gene 1993; 131(2): 307-308.

15. Kroeger K, Abraham L. Identification of an AP-2 element in the –323 to –285 region of the TNF-a gene. Biochem Mol Biol Int 1996; 40(1):43-51.

16. Stanulla M, Schrauder A, Welte K, Schrappe M. Tumor necrosis factor and lymphotoxine-a genetic poly­morphisms and risk of relapse in childhood b-cell precur­sor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy. BMC Blood Disorders 2001; 1(1):2.

17. Takeuchi S, Takeuchi N, Tsukasaki K, Bartram C, Zimmermann M, Schrappe M, Taguchi H, Koefeler H. Genetic polymorphisms in the tumor necrosis factor locus in childhood acute lymphoblastic leukemia. Br J Haema­tol 2002; 119(4): 985-987.

 

 





Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006